"Megestrol Acetate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)
| Descriptor ID |
D019290
|
| MeSH Number(s) |
D04.210.500.745.432.531.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Megestrol Acetate".
Below are MeSH descriptors whose meaning is more specific than "Megestrol Acetate".
This graph shows the total number of publications written about "Megestrol Acetate" by people in this website by year, and whether "Megestrol Acetate" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Megestrol Acetate" by people in Profiles.
-
Panwalker AP. Hyperglycemia induced by megestrol acetate. Ann Intern Med. 1992 May 15; 116(10):878.
-
Schlaff WD, Dugoff L, Damewood MD, Rock JA. Megestrol acetate for treatment of endometriosis. Obstet Gynecol. 1990 Apr; 75(4):646-8.
-
Muss HB, Wells HB, Paschold EH, Black WR, Cooper MR, Capizzi RL, Christian R, Cruz JM, Jackson DV, Powell BL, et al. Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association. J Clin Oncol. 1988 Jul; 6(7):1098-106.